¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"variable surface glycoprotein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • dorsal surface
    µîÂʸé, µÞ¸é, ¹èÃø¸é
  • fetal surface
    žÆ(ÂÊ)¸é
  • free surface
    ÀÚÀ¯¸é
  • hepatitis B surface antigen
    BÇü°£¿°Ç¥¸éÇ׿ø
  • internal surface
    ¼Ó¸é, ³»¸é
  • lateral surface
    °¡Âʸé, ¿ÜÃø¸é, Ãø¸é
  • occlusal surface
    ±³ÇÕ¸é, ¸Â¹°¸²¸é
  • potential surface
    ÀüÀ§¸é
  • proximate surface
    ÀÎÁ¢¸é
  • quadratic surface
    ÀÌÂ÷°î¸é
  • root surface cavity
    Ä¡¾Æ»Ñ¸®¸é°ø°£
  • source-surface distance
    ¿øÃµÇ¥¸é»çÀ̰Ÿ®, ¿øÃµÇ¥¸é°£°Å¸®
  • surface
    1. Ç¥¸é 2. ¸é
  • surface anesthesia
    Ç¥¸é¸¶Ãë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • manifestational variable
    Á¾¼Óº¯¼ö
  • moderator variable
    Á¶Á¾º¯¼ö
  • variable orifice meter
    º¯À̼º±¸°æ°è
  • passenger variable
    µ¿¹Ýº¯¼ö
  • variable region
    °¡º¯ºÎÀ§
  • variable strabismus
    °¡º¯»ç½Ã
  • variable bandwidth technique
    ´Ùº¯Á֯ļöÆø±â¹ý
  • variable
    º¯¼ö, °¡º¯
  • anterolateral surface
    ¾Õ°¡Âʸé
  • anteromedial surface
    ¾Õ¾ÈÂʸé
  • approximal surface
    Á¢Ã˸é
  • articular surface
    °üÀý¸é
  • hepatitis B surface antigen
    ºñÇü°£¿°Ç¥¸éÇ׿ø
  • surface anesthesia
    Ç¥¸é¸¶Ãë
  • surface antigen
    Ç¥¸éÇ׿ø
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anterior surface of petrous portion
    ¹ÙÀ§¾Õ¸é
  • anterolateral surface
    ¾Õ°¡Âʸé
  • anteromedial surface
    ¾Õ¾ÈÂʸé
  • antigen, hepatitis B surface
    BÇü °£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø
  • approximal surface
    Á¢Ã˸é
  • articular surface
    °üÀý ¸é(¡­Øü).
  • articular surface
    °üÀý¸é
  • articular surface for cuboid bone
    ÀÔ¹æ°üÀý¸é
  • articular surface for fibula
    Á¾¾Æ¸®°üÀý¸é
  • articular surface for navicular bone
    ¹ß¹è°üÀý¸é
  • articular surface of fibular head
    Á¾¾Æ¸®»À¸Ó¸®°üÀý¸é
  • articular surface of head of rib
    °¥ºñ»À¸Ó¸®°üÀý¸é
  • articular surface of tubercle
    °¥ºñ»À°áÀý°üÀý¸é
  • gastric surface
    À§¸é
  • glenoid surface
    °üÀý¿Í¸é(μï½èÀØü).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intensity variable
    °­µµº¯¼ö.
  • intermediate variable
    Áß°£º¯¼ö.
  • region, variable
    °¡º¯ºÎÀ§ (¸é¿ª±Û·ÎºÒ¸°ÀÇ)
  • variable bandwidth technique
    ´Ùº¯ Á֯ļöÆø ±â¹ý
  • variable condenser
    °¡º¯ÃàÀü±â(ʦܨ õêï³Ñ¦).
  • variable coupling
    °¡º¯½Ä¿¬°á.
  • variable factor
    °¡º¯ÀÎÀÚ(ʦܨì×í­).
  • variable numbers
    º¯¼ö(ËÒËà).
  • variable of integration
    ÀûºÐº¯¼ö.
  • variable orifice meter
    º¯À̼º ±¸°æ°è.
  • variable region
    °¡º¯ºÎÀ§(ʦܨݻêÈ).
  • variable repeat of tandem repeats
    ¹Ýº¹À¯ÀüÀÚÀÇ ÀÓÀǹݺ¹(ìòëòÚãÜÖ)
  • variable strabismus
    °¡º¯»ç½Ã
  • variable(s)
    º¯¼ö(ܨâ¦), º¯ÀÎ(ܨì×).
  • anterior articular surface
    ¾Õ°üÀý¸é
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Viceral surface
    ³»Àå¸é
    [¿¾ ¿ë¾î] ÀåÃø¸é
  • Visceral surface
    ³»Àå¸é
    [¿¾ ¿ë¾î] ÀåÃø¸é
  • Posterior surface of eyelids
    ´«²¨Ç®µÚ¸é
    [¿¾ ¿ë¾î] ¾È°ËÈĸé
  • Anterior surface of eyelid
    ´«²¨Ç®¾Õ¸é
    [¿¾ ¿ë¾î] ¾È°ËÀü¸é
  • Orbital surface
    ´«È®¸é
    [¿¾ ¿ë¾î] ¾È¿Í¸é
  • Cerebral surface
    ´ë³ú¸é
    [¿¾ ¿ë¾î] ´ë³ú¸é
  • Symphyseal surface
    µÎµ¢°áÇÕ¸é
    [¿¾ ¿ë¾î] Ä¡°ñ°áÇÕ¸é
  • Posterior articular surface
    µÚ°üÀý¸é
    [¿¾ ¿ë¾î] ÈİüÀý¸é
  • Dorsal surface
    µÚ¸é
    [¿¾ ¿ë¾î] Èĸé
  • Intestinal surface
    µÚ¸é
    [¿¾ ¿ë¾î] Èĸé
  • Posterior surface
    µÚ¸é
    [¿¾ ¿ë¾î] Èĸé
  • Posterior articular surface for talus
    µÚ¸ñ¸»°üÀý¸é
    [¿¾ ¿ë¾î] ÈİŰñ°üÀý¸é
  • Posterior calcaneal articular surface
    µÚ¹ß²ÞÄ¡°üÀý¸é
    [¿¾ ¿ë¾î] ÈÄÁ¾°ñ°üÀý¸é
  • Dorsal surface
    µî¸é
    [¿¾ ¿ë¾î] ¹èÃø¸é
  • Dorsal surface
    µîÂʸé
    [¿¾ ¿ë¾î] ¹èÃø¸é
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • surface antigen
    Ç¥¸éÇ׿ø (øúØüù÷ê«)
  • surface balance
    Ç¥¸é(øúØü) Àú¿ï
  • surface factor
    Ç¥¸éÀÎÀÚ (øúØüì×í­)
  • surface membrane proteins
    Ç¥¸é¸·´Ü¹éÁú (øúØüدӱÛÜòõ)
  • surface potential
    Ç¥¸éÀüÀ§ (øúØüï³êÈ)
  • surface pressure
    Ç¥¸é¾Ð (øúØüäâ)
  • surface tension
    Ç¥¸éÀå·Â (øúØüíåÕô)
  • van der Waals surface
    ¹Ý µ§ ¹ß½º Ç¥¸é (øúØü)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • symphysial surface
    Ä¡°ñ°áÇÕ¸é
  • tuning of surface coil
    Ç¥¸é ÄÚÀÏÁ¶À², Ç¥¸é°ËÃâ±âÁ¶Á¤
  • ventromedial surface
    ³»ÃøÀü¸é, º¹³»Ãø
  • wound surface
    â¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SGP serine glycerophosphatide; sialoglycoprotein; Society of General Physiologists; soluble glycoprotein...
AMLSGA acute myeloblastic leukemia surface glycoprotein antigen
VSG variant surface glycoprotein
ESA Electrolysis Society of America; endocardial surface area; epidermal surface antigen; esterase; este...
SA salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CVID Common Variable Immuno-Deficiency
CVH Common variable hypogammaglobulinemia
CVI Common variable immunodeficiency
HVR Hyper-Variable Region
scFv Single chain variable fragments
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bony surface of the joint
    °üÀý °ñ¸é
  • boundary surface
    °è¸é
    µ¿ÀǾî=interface.
  • cardiac surface map
    ½ÉÀå Ç¥¸éµµ
  • cell surface marker
    ¼¼Æ÷ Ç¥¸é Ç¥ÁöÀÚ
  • contact surface
    Á¢Ã˸é
    °£È¤ »óÇÏ Ä¡¾Æ°£ ±³ÇÕ¸é Á¢ÃËÀ» °¡¸®Å°´Â °æ¿ìµµ ÀÖ´Ù.
  • costal surface
    ´Á°ñ ¸é
  • disc-articular surface adherence
    °üÀý¿øÆÇ-°üÀý ¸é À¯Âø
  • dorsal surface of finger
    ¼Õ°¡¶ô µî
  • equipotential surface
    µîÀüÀ§ ¸é
  • exposed surface
    ³ëÃâ¸é
  • fatty coating of surface
    Ç¥¸éÀÌ Áö¹æÀ¸·Î µ¤Çô ÀÖ´Â
  • flexor surface
    ±¼°î¸é, ±¼±Ù¸é
  • free surface
    ÀÚÀ¯ ¸é
  • high surface
    °íÇ¥¸é
  • impression of root surface
    ±Ù¸é Àλó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
discrete variable A variable that may assume only a countable (usually finite) number of values.
(05 Mar 2000)
immunoglobulin variable region That region of the immunoglobulin (antibody) molecule that varies in its amino acid sequence and composition, confers the antigenic specificity, and is thought to comprise the binding site for the antigen. It is located at the n-terminus of the fab fragment of the immunoglobulin. It includes hypervariable and framework regions, vh family subgroups, and the complementarity-determining region.
(12 Dec 1998)
independent variable A characteristic being measured or observed that is hypothesised to influence another event or manifestation (the dependent variable) within a defined area of relationships under study; that is, the independent variable is not influenced by the event or manifestation, but may cause it or contribute to its variation.
See: dependent variable.
(05 Mar 2000)
intermediate variable A variable in a causal pathway that causes variation in the dependent variable and is itself caused to vary by the independent variable.
(05 Mar 2000)
intervening variable An event, such as an attitude or emotion, inferred to occur within an organism between the stimulation and response in such a way as to influence or determine the response.
(05 Mar 2000)
a1-acid glycoprotein <biology> Plasma protein of mammals and birds, 38% carbohydrate. In humans a single chain glycoprotein of 39 kD. Increased levels are associated with inflammation, pregnancy and various diseases.
(18 Nov 1997)
acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase <enzyme> Forms oligosaccharide core class 3 (glcnac beta 1-3galnac) in mucins and various glycoproteins
Registry number: EC 2.4.1.147
Synonym: udp-glcnac-galnac-r beta 3-acetylglucosaminyltransferase, agggag-transferase
(26 Jun 1999)
amyloidogenic glycoprotein <protein> An integral membrane glycoprotein of the brain and related to the Drosophila vnd gene product. A precursor of _ amyloid, that accumulates in Alzheimer's disease and Down's syndrome.
See: amyloid precursor protein.
(18 Nov 1997)
b2-glycoprotein II <enzyme> A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor b is converted by factor d to c3 convertase.
Registry number: EC 3.4.21.47
(12 Dec 1998)
beta-1,3-galactosyl-0-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase <enzyme> Capable of adding a glcnac residue to g1cnacman(3)g1cnac; from mung bean seedlings
Registry number: EC 2.4.1.146
Synonym: n-acetylglucosaminyltransferase II, gal3-(glcnac6)galnac-mucin (glcnac--gal)3-glcnactransferase
(26 Jun 1999)
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-acetylglucosaminyl transferase <enzyme> With EC 2.4.1.148 this is called beta6-glcnac-transferase b
Registry number: EC 2.4.1.102
Synonym: gal3-galnac-mucin-6-glcnac transferase, udp-glcnac-gal1-3galnac-r-(glcnac to galnac)-beta1-6glcnac transferase, core 2 glcnac transferase, core 2-n-acetylglucosaminyltransferase, core 2 beta6-gn-t
(26 Jun 1999)
beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase <enzyme> Induced in preneoplastic stage of liver carcinogenesis promoted by orotic acid in rats; adds "bisecting n-acetylglucosaminyl residue in beta 1,4 linkage to the beta-linked mannose of the core of asparagine-linked oligosaccharides
Registry number: EC 2.4.1.144
Synonym: n-acetylglucosaminyltransferase III, udpgnac-glycopeptide beta4-n-acetylglucosaminyl transferase III, udpgnac-magtransferase III, udp-n-acetylglucosamine-beta-d-mannoside beta-1,4-n-acetylglucosaminyltransferase III
(26 Jun 1999)
carbohydrate-deficient glycoprotein syndrome <syndrome> An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors.
(12 Dec 1998)
mannosyl-glycoprotein endo-beta-n-acetylglucosaminidase <enzyme> A group of related enzymes responsible for the endohydrolysis of the di-n-acetylchitobiosyl unit in high-mannose-content glycopeptides and glycoproteins.
Chemical name: Glycopeptide-D-mannosyl-N(4)-(N-acetyl-D-glucosaminyl)2-asparagine 1,4-N-acetyl-beta-glucosaminohydrolase
Registry number: EC 3.2.1.96
(12 Dec 1998)
glycine-rich beta-glycoprotein <enzyme> A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor b is converted by factor d to c3 convertase.
Registry number: EC 3.4.21.47
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • surface printing
    ºí·ÏÆÇ Àμâ(³¯¿°)
  • surface tension
    Ç¥¸é Àå·Â
  • surface water
    ÁöÇ¥¼ö(ÁöÇϼö¿¡ ´ëÇØ);Ç¥¸é ¼ö·®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á